144 related articles for article (PubMed ID: 9219186)
1. Use of influence diagrams to structure medical decisions.
Nease RF; Owens DK
Med Decis Making; 1997; 17(3):263-75. PubMed ID: 9219186
[TBL] [Abstract][Full Text] [Related]
2. Representation and analysis of medical decision problems with influence diagrams.
Owens DK; Shachter RD; Nease RF
Med Decis Making; 1997; 17(3):241-62. PubMed ID: 9219185
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
[TBL] [Abstract][Full Text] [Related]
4. Cost-minimization analysis of alternative diagnostic approaches in a modeled patient with non-small cell lung cancer and subcarinal lymphadenopathy.
Harewood GC; Wiersema MJ; Edell ES; Liebow M
Mayo Clin Proc; 2002 Feb; 77(2):155-64. PubMed ID: 11838649
[TBL] [Abstract][Full Text] [Related]
5. Cost-benefit of minimally invasive staging of non-small cell lung cancer: a decision tree sensitivity analysis.
Steinfort DP; Liew D; Conron M; Hutchinson AF; Irving LB
J Thorac Oncol; 2010 Oct; 5(10):1564-70. PubMed ID: 20871261
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and cost-effectiveness of alternative staging strategies for non-small-cell lung cancer.
Esnaola NF; Lazarides SN; Mentzer SJ; Kuntz KM
J Clin Oncol; 2002 Jan; 20(1):263-73. PubMed ID: 11773178
[TBL] [Abstract][Full Text] [Related]
7. Cost-efficacy of endoscopic ultrasonography with fine-needle aspiration vs. mediastinotomy in patients with lung cancer and suspected mediastinal adenopathy.
Aabakken L; Silvestri GA; Hawes R; Reed CE; Marsi V; Hoffman B
Endoscopy; 1999 Nov; 31(9):707-11. PubMed ID: 10604611
[TBL] [Abstract][Full Text] [Related]
8. Mediastinal staging in non-small-cell lung cancer.
Malenka DJ; Colice GL; Jacobs C; Beck JR
Med Decis Making; 1989; 9(4):231-42. PubMed ID: 2552250
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of strategies introducing integrated ¹⁸F-FDG PET/CT into the mediastinal lymph node staging of non-small-cell lung cancer.
Han Y; Xiao H; Zhou Z; Yuan M; Zeng Y; Wu H; Fang Y
Nucl Med Commun; 2015 Mar; 36(3):234-41. PubMed ID: 25460305
[TBL] [Abstract][Full Text] [Related]
10. The optimality of different strategies for supplemental staging of non-small-cell lung cancer: a health economic decision analysis.
Søgaard R; Fischer BM; Mortensen J; Rasmussen TR; Lassen U
Value Health; 2013; 16(1):57-65. PubMed ID: 23337216
[TBL] [Abstract][Full Text] [Related]
11. A decision analytic method for scoring performance on computer-based patient simulations.
Downs SM; Friedman CP; Marasigan F; Gartner G
Proc AMIA Annu Fall Symp; 1997; ():667-71. PubMed ID: 9357709
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic ultrasound-guided fine-needle aspiration in patients with non-small cell lung cancer and prior negative mediastinoscopy.
Eloubeidi MA; Tamhane A; Chen VK; Cerfolio RJ
Ann Thorac Surg; 2005 Oct; 80(4):1231-9. PubMed ID: 16181845
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic reasoning and medical decision-making with fuzzy influence diagrams.
Kao HY
Comput Methods Programs Biomed; 2008 Apr; 90(1):9-16. PubMed ID: 18192070
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness Analysis with Influence Diagrams.
Arias M; Díez FJ
Methods Inf Med; 2015; 54(4):353-8. PubMed ID: 25762363
[TBL] [Abstract][Full Text] [Related]
15. Mediastinal staging for lung cancer: the influence of biopsy volume.
Nelson E; Pape C; Jørgensen OD; Olsen KE; Licht PB
Eur J Cardiothorac Surg; 2010 Jan; 37(1):26-9. PubMed ID: 19695900
[TBL] [Abstract][Full Text] [Related]
16. Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework.
Briggs AH; Ades AE; Price MJ
Med Decis Making; 2003; 23(4):341-50. PubMed ID: 12926584
[TBL] [Abstract][Full Text] [Related]
17. Markov Influence Diagrams.
Díez FJ; Yebra M; Bermejo I; Palacios-Alonso MA; Calleja MA; Luque M; Pérez-Martín J
Med Decis Making; 2017 Feb; 37(2):183-195. PubMed ID: 28076183
[TBL] [Abstract][Full Text] [Related]
18. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
[TBL] [Abstract][Full Text] [Related]
19. Echo-endoscopic lymph node staging in lung cancer: an endoscopic alternative.
Hegde P; Liberman M
Expert Rev Anticancer Ther; 2015; 15(9):1063-73. PubMed ID: 26165589
[TBL] [Abstract][Full Text] [Related]
20. Tutorial of the probabilistic methods Bayesian networks and influence diagrams applied to medicine.
Nistal-Nuño B
J Evid Based Med; 2018 May; 11(2):112-124. PubMed ID: 29878581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
